BCR-ABL+acute lymphoblastic leukemia (ALL) in adults has a poor prognosis with allogeneic stem cell transplantation (SCT) considered the best curative option for suitable patients. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.